Singapore markets close in 5 hours 4 minutes

VRTX Apr 2024 470.000 call

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
3.5000+1.6000 (+84.21%)
As of 02:36PM EST. Market open.
Full screen
Previous close1.9000
Expiry date2024-04-19
Day's range2.2700 - 3.5000
Contract rangeN/A
Open interest200

    Vertex Pharmaceuticals EVP, Global Research and CSO David Altshuler Sells 4,002 Shares

    David Altshuler, EVP, Global Research and CSO of Vertex Pharmaceuticals Inc (NASDAQ:VRTX), sold 4,002 shares of the company on February 20, 2024, according to a recent SEC filing.

  • Business Wire

    Vertex to Participate in Upcoming Investor Conferences

    BOSTON, February 20, 2024--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Charles Wagner, Executive Vice President and Chief Financial Officer, and David Altshuler, M.D., Ph.D., Executive Vice President, Global Research, and Chief Scientific Officer, will participate in two upcoming investor conferences:

  • Insider Monkey

    15 Most Expensive Medical Treatments/Procedures In The World

    In this article, we will be taking a look at the 15 most expensive medical treatments/procedures in the world. If you are not interested in reading about the landscape of expensive medical treatments, head straight to the 5 Most Expensive Medical Treatments/Procedures In The World. In today’s ever-evolving landscape of medical advancements, some treatments and […]